Status:
COMPLETED
Dual Diagnosis (Psychosis and Cannabismisuse): Comparison of Specialized Treatment Versus Unspecified Treatment
Lead Sponsor:
University of Konstanz
Conditions:
Psychotic Disorders
Marijuana Abuse
Eligibility:
All Genders
18-65 years
Phase:
PHASE1
Brief Summary
Intention of the study is to examine, if the symptomatology of dual diagnosis patients is less severe after a special indication training for reduction of cannabis consumption in comparison to unspeci...
Detailed Description
Dual diagnosis patients (psychosis and cannabis abuse) account for more clinical admissions than single diagnosis patients. Cannabis misuse is a known risk factor for recurrence of psychosis. A spec...
Eligibility Criteria
Inclusion
- Clinical diagnosis of schizophrenia and disorders with psychotic features
- Misuse of cannabis during 12 months preceding admission to hospital
Exclusion
- Not able to attend training twice a week for 45 minutes (concentration, attention, psychotic symptoms, agitation)
- Discharge from hospital before completion of training
Key Trial Info
Start Date :
January 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 1 2010
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT00783185
Start Date
January 1 2006
End Date
January 1 2010
Last Update
January 12 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Konstanz
Konstanz, Baden-Wurttemberg, Germany, 78462